JPWO2004024188A1 - 薬物の血漿蛋白質結合を制御するための製剤 - Google Patents

薬物の血漿蛋白質結合を制御するための製剤 Download PDF

Info

Publication number
JPWO2004024188A1
JPWO2004024188A1 JP2004535917A JP2004535917A JPWO2004024188A1 JP WO2004024188 A1 JPWO2004024188 A1 JP WO2004024188A1 JP 2004535917 A JP2004535917 A JP 2004535917A JP 2004535917 A JP2004535917 A JP 2004535917A JP WO2004024188 A1 JPWO2004024188 A1 JP WO2004024188A1
Authority
JP
Japan
Prior art keywords
active ingredient
preparation
derivatives
amino acids
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004535917A
Other languages
English (en)
Japanese (ja)
Inventor
恵一 川井
恵一 川井
高村　徳人
徳人 高村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nihon Medi Physics Co Ltd
Original Assignee
Nihon Medi Physics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Medi Physics Co Ltd filed Critical Nihon Medi Physics Co Ltd
Publication of JPWO2004024188A1 publication Critical patent/JPWO2004024188A1/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2004535917A 2002-09-12 2003-09-09 薬物の血漿蛋白質結合を制御するための製剤 Pending JPWO2004024188A1 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002267010 2002-09-12
JP2002267010 2002-09-12
PCT/JP2003/011516 WO2004024188A1 (fr) 2002-09-12 2003-09-09 Preparation permettant de reguler la liaison d'un medicament a une proteine plasmatique

Publications (1)

Publication Number Publication Date
JPWO2004024188A1 true JPWO2004024188A1 (ja) 2006-01-05

Family

ID=31986678

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004535917A Pending JPWO2004024188A1 (ja) 2002-09-12 2003-09-09 薬物の血漿蛋白質結合を制御するための製剤

Country Status (4)

Country Link
JP (1) JPWO2004024188A1 (fr)
AU (1) AU2003262025A1 (fr)
TW (1) TWI306762B (fr)
WO (1) WO2004024188A1 (fr)

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54145220A (en) * 1978-04-24 1979-11-13 Massachusetts Inst Technology Blood pressure lowering composition
JPS60208911A (ja) * 1984-03-28 1985-10-21 Green Cross Corp:The ジアゼパム直腸投与製剤
JPH06336442A (ja) * 1993-04-02 1994-12-06 Wakamoto Pharmaceut Co Ltd 安定なリポソーム水分散液
JPH07508019A (ja) * 1992-05-06 1995-09-07 ジヤンセン・フアーマシユーチカ・インコーポレーテツド 医薬および他の製剤
JPH07267855A (ja) * 1994-03-30 1995-10-17 Taiho Yakuhin Kogyo Kk グルタミン産生剤
JPH0920656A (ja) * 1995-07-06 1997-01-21 Otsuka Pharmaceut Factory Inc アミノ酸輸液製剤
WO1999008709A1 (fr) * 1997-08-14 1999-02-25 Daiichi Radioisotope Laboratories, Ltd. Medicament radioactif stable
WO1999059552A1 (fr) * 1998-05-15 1999-11-25 Chugai Seiyaku Kabushiki Kaisha Preparations a liberation controlee
WO2000043035A1 (fr) * 1999-01-19 2000-07-27 Nissho Corporation Preparations d'albumine a base d'acides amines
WO2000078352A1 (fr) * 1999-06-21 2000-12-28 Nihon Medi-Physics Co., Ltd. Procede d'administration de medicaments possedant une affinite de liaison aux proteines plasmatiques et preparation utilisee pour la mise en oeuvre dudit procede
JP2001163780A (ja) * 1999-12-03 2001-06-19 Tanabe Seiyaku Co Ltd 総合栄養輸液剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374857A (en) * 1982-01-25 1983-02-22 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence Method of inhibiting L-tryptophan to serum albumin binding
US4600708A (en) * 1985-07-19 1986-07-15 American Home Products Corporation Propranolol hydrochloride liquid formulations
HUP9701554D0 (en) * 1997-09-18 1997-11-28 Human Oltoanyagtermeloe Gyogys Pharmaceutical composition containing plazma proteins

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54145220A (en) * 1978-04-24 1979-11-13 Massachusetts Inst Technology Blood pressure lowering composition
JPS60208911A (ja) * 1984-03-28 1985-10-21 Green Cross Corp:The ジアゼパム直腸投与製剤
JPH07508019A (ja) * 1992-05-06 1995-09-07 ジヤンセン・フアーマシユーチカ・インコーポレーテツド 医薬および他の製剤
JPH06336442A (ja) * 1993-04-02 1994-12-06 Wakamoto Pharmaceut Co Ltd 安定なリポソーム水分散液
JPH07267855A (ja) * 1994-03-30 1995-10-17 Taiho Yakuhin Kogyo Kk グルタミン産生剤
JPH0920656A (ja) * 1995-07-06 1997-01-21 Otsuka Pharmaceut Factory Inc アミノ酸輸液製剤
WO1999008709A1 (fr) * 1997-08-14 1999-02-25 Daiichi Radioisotope Laboratories, Ltd. Medicament radioactif stable
WO1999059552A1 (fr) * 1998-05-15 1999-11-25 Chugai Seiyaku Kabushiki Kaisha Preparations a liberation controlee
WO2000043035A1 (fr) * 1999-01-19 2000-07-27 Nissho Corporation Preparations d'albumine a base d'acides amines
WO2000078352A1 (fr) * 1999-06-21 2000-12-28 Nihon Medi-Physics Co., Ltd. Procede d'administration de medicaments possedant une affinite de liaison aux proteines plasmatiques et preparation utilisee pour la mise en oeuvre dudit procede
JP2001163780A (ja) * 1999-12-03 2001-06-19 Tanabe Seiyaku Co Ltd 総合栄養輸液剤

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ANALYTICAL BIOCHEMISTRY, vol. 113, JPN6008052415, 1981, pages 407 - 415, ISSN: 0001158476 *
INT. J. BIOCHEM., vol. 14, JPN6008052479, 1982, pages 295 - 304, ISSN: 0001158474 *
NEUROPHARMACOLOGY, vol. 17(6), JPN6008052416, 1978, pages 428 - 430, ISSN: 0001158477 *
RESEARCH COMMUNICATIONS OIN CHEMICAL PATHOLOGY AND PHARMACOLOGY, vol. 8(3), JPN6008052413, 1974, pages 563 - 566, ISSN: 0001158475 *

Also Published As

Publication number Publication date
TW200404577A (en) 2004-04-01
TWI306762B (en) 2009-03-01
WO2004024188A1 (fr) 2004-03-25
AU2003262025A1 (en) 2004-04-30

Similar Documents

Publication Publication Date Title
Verbruggen et al. Technetium-99m-L, L-ethylenedicysteine: a renal imaging agent. I. Labeling and evaluation in animals
JPH06507908A (ja) 関節炎の処理のための放射性ラベルされた金属結合性タンパク質
McAfee et al. Comparison of renal extraction efficiencies for radioactive agents in the normal dog
US20060140857A1 (en) Method of the administration of drugs with binding affinity for plasma protein and preparation to be used in the method
JP7436512B2 (ja) 腎保護物質としてのパラアミノ馬尿酸（ｐａｈ）
CA2915708C (fr) Compositions et procedes utilisables en vue de la preparation d'agents protecteurs renaux contenant de l'amifostine et des acides amines
JP2005516933A (ja) 放射性医薬による骨髄炎の治療
IE921125A1 (en) Radiopharmaceutical Bacteriostats
Pinkerton et al. Bioinorganic activity of technetium radiopharmaceuticals
JP2003504395A (ja) 腎臓に有害な可能性のある分子の腎臓取り込みの阻害
JP2021113207A (ja) 放射性同位体用ｄｏｔｍｐキット製剤
Komal et al. Localization Mechanisms of Radiopharmaceuticals
JPWO2004024188A1 (ja) 薬物の血漿蛋白質結合を制御するための製剤
EP0438502B1 (fr) Agents d'imagerie a base de technetium
US10363324B2 (en) Pharmaceutical composition
AU2016297308B2 (en) Composition for stabilizing radiochemical purity of [18F]fluoro-dopa and method for preparing same
RU2804349C2 (ru) Парааминогиппуровая кислота (паг) как вещество для защиты почек
Batlle et al. Proximal renal tubular acidosis and hypophosphatemia induced by arginine
Arano Recent advances in 99mTc radiopharmacenticals
JP2005112750A (ja) 腎臓トランスポーターによる薬物動態の制御方法および製剤
TW202017600A (zh) 用於放射性醫藥之含有體抑素類似物之組成物
KR100417218B1 (ko) ＴＣ-99ｍ 트리카보닐 시스테인 또는 그 유도체를포함하는 신장기능 진단용 방사성의약품
Ponto Radiopharmaceuticals and dialysis
Class et al. Patent application title: COMPOSITIONS AND METHODS FOR THE PREPARATION OF KIDNEY PROTECTIVE AGENTS COMPRISING AMIFOSTINE AND AMINO ACIDS Inventors: Ebrahim Delpassand (Houston, TX, US) Izabela Tworowska (Houston, TX, US) Sanjay Thamake (Houston, TX, US) David Ranganathan (Houston, TX, US)
Cox Radiopharmaceuticals

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20081017

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081216

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20081216

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20091030